Novartis forges UC Berkeley pact, sees drug hopefuls in three years

Share this post

ZURICH (Reuters) – Novartis’s NOVN.S research head expects an alliance with a University of California chemistry lab to produce drug candidates within three years as the Swiss company accelerates its hunt for new medicines.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply